Lan Xu
Senior Vice President - Translational Medicine Polymed Biopharmaceuticals
Accomplished scientific leader with 20-year experience in drug discovery, translational sciences and early development in biotech industry and academia. Demonstrated success in driving multiple oncology and rare genetic disease programs to IND and phase 1 clinical trials. A strong track record in turning novel therapeutic ideas into first-in-class clinical assets that resulted in partnership deals with pharmaceutical companies. Led design and implementation of translational and biomarker strategies in oncology clinical trials. Innovative research leader with an excellent publication record. Motivational and engaged team leader with strong communication and interpersonal skills.
Seminars
- Enabling pan-KRAS/pan-RAS targeting with a potentially improved therapeutic window through antibody-guided DAC technology
- Delivering differentiated biology beyond inhibition by degrading RAS proteins and disrupting downstream signaling pathways
- Advancing toward clinical validation with a growing portfolio of RAS degraders and imminent clinical candidate progression
